Understanding why cancer patients stop taking their medications
Prediction of Anti-Cancer Medication Discontinuation via Patient Portal Messages and Structured Electronic Medical Records
This study looks at why some people with hormone-receptor-positive breast cancer stop taking their oral anti-cancer medications, so we can help doctors better support patients and improve their treatment success.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11123119 on NIH RePORTER |
What this research studies
This research investigates the reasons behind the discontinuation of oral anti-cancer medications among patients, particularly those with hormone-receptor-positive breast cancer. By analyzing patient portal messages and structured electronic medical records, the study aims to identify factors that contribute to medication adherence. The goal is to provide healthcare providers with insights that can help improve patient support and treatment compliance, ultimately enhancing patient outcomes. The research employs a combination of data analysis and patient communication to understand the challenges faced by patients in maintaining their treatment regimens.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with hormone-receptor-positive breast cancer who are prescribed long-term oral anti-cancer therapies.
Not a fit: Patients who are not undergoing treatment with oral anti-cancer medications or those with non-hormone-receptor-positive breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for helping cancer patients adhere to their medication regimens, potentially increasing survival rates and reducing healthcare costs.
How similar studies have performed: Previous research has shown success in understanding medication adherence through patient communication and electronic health records, indicating that this approach has potential for meaningful insights.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Yin, Zhijun — Vanderbilt University Medical Center
- Study coordinator: Yin, Zhijun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.